Skip to main content
J2KBIO Co., Ltd. logo

J2KBIO Co., Ltd. — Investor Relations & Filings

Ticker · 420570 ISIN · KR7420570004 KO Manufacturing
Open in API
Filings indexed 53 across all filing types
Latest filing 2025-03-28 Declaration of Voting R…
Country KR South Korea
Listing KO 420570

About J2KBIO Co., Ltd.

https://www.j2kbio.com/eng/

J2KBIO Co., Ltd. is a research and development-focused bio-venture company that designs and develops active ingredients and sustainable raw materials. The company utilizes natural ingredients and microorganisms, employing advanced processes such as microbial fermentation and its proprietary METABIOME technology. Its research focuses on exploring the interactions between its ingredients and the skin to discover materials with optimal efficacy. The resulting bio-materials are supplied for use in a variety of sectors, including cosmetics, personal care products, functional foods, and household goods. The company is committed to developing safe and beneficial ingredients for skin application while promoting a sustainable coexistence between people and nature.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides the official outcomes of the shareholder meeting held on 2025-03-28, including the approval of financial statements, dividend resolutions, and board-related matters. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-03-28 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for J2K Bio. It contains the meeting agenda, details on voting procedures, and financial statements (balance sheet, income statement, etc.) as part of the management's reference materials for shareholders. This type of document is standard for an Annual General Meeting and is classified as AGM-R.
2025-03-24 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for J2K Bio (주식회사 제이투케이바이오) for the fiscal year ending December 31, 2024. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. This constitutes a comprehensive annual financial report for the company, which falls under the 'Annual Report' (10-K) category in the provided schema. FY 2024
2025-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It provides the audit opinion (unqualified/proper), key financial data (assets, liabilities, equity, profit/loss), and details regarding the auditor (Hanul Accounting Corp). While it contains financial data, it is a standard regulatory disclosure announcement regarding the submission of the audit report, which is a mandatory filing requirement in the Korean market. It fits the 'Audit Report / Information' category as it specifically reports the results of the audit process. FY 2024
2025-03-20 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from J2K Bio regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares issued, the conversion price, and the remaining balance of convertible bonds. This type of disclosure regarding capital structure changes and the conversion of debt into equity falls under the category of share issue or capital change announcements.
2025-03-07 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by J2K Bio. It outlines the date, location, and agenda items (such as approval of financial statements and director compensation) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2025-02-14 Korean

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.